(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OXAPEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OXAPEX

ST13

US500000087780730

Class

5

Filing

87780730

Registration

6784317

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

04/21/2023

Trademark type

Word

Nice classes

5

Filing date

02/01/2018

Registration date

07/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/12/2022

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

SHEUNG WAN, HK

Examiner

NELMAN, JESSE M

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

FIRST GAIN INTERNATIONAL LIMITED
Hong Kong Cytogenetics and Medical Genetics Centre Limited

Representatives

Timothy T. Wang NI, WANG & MASSAND, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorderstissue hypoxiashock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposessterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; biological preparations for medical and veterinary purposeshemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; Biological preparations for medical and veterinary purposesprotein arraysbiological tissue culturesbloodblood plasmablood serums for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases

Publications

History of USPTO decisions and trademark events.

57 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/26/2022

PUBO

PUBLISHED FOR OPPOSITION

04/26/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/06/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/10/2022

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

03/09/2022

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

03/09/2022

APET

ASSIGNED TO PETITION STAFF

03/07/2022

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

02/25/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/18/2022

EX5G

SOU EXTENSION 5 GRANTED

02/17/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/17/2022

EXT5

SOU EXTENSION 5 FILED

02/10/2022

EEXT

SOU TEAS EXTENSION RECEIVED

02/10/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/25/2021

EX4G

SOU EXTENSION 4 GRANTED

08/23/2021

EXT4

SOU EXTENSION 4 FILED

08/23/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/23/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/20/2021

EX3G

SOU EXTENSION 3 GRANTED

02/18/2021

EXT3

SOU EXTENSION 3 FILED

02/18/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/18/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/15/2020

EX2G

SOU EXTENSION 2 GRANTED

08/13/2020

EXT2

SOU EXTENSION 2 FILED

08/13/2020

EEXT

SOU TEAS EXTENSION RECEIVED

08/13/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/27/2020

EX1G

SOU EXTENSION 1 GRANTED

02/25/2020

EXT1

SOU EXTENSION 1 FILED

02/25/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/25/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/03/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/09/2019

PUBO

PUBLISHED FOR OPPOSITION

07/09/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/19/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

06/06/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/06/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

06/06/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/06/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

05/30/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/20/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/20/2018

GNSL

LETTER OF SUSPENSION E-MAILED

11/20/2018

CNSL

SUSPENSION LETTER WRITTEN

11/20/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/19/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/15/2018

GNRT

NON-FINAL ACTION E-MAILED

05/15/2018

CNRT

NON-FINAL ACTION WRITTEN

05/15/2018

DOCK

ASSIGNED TO EXAMINER

05/15/2018

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

03/07/2018

ALIE

ASSIGNED TO LIE

03/05/2018

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

02/20/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/11/2018

NWAP

NEW APPLICATION ENTERED

02/05/2018

Continuous trademark protection

Get notified about every new filing that threatens OXAPEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.